Pharmacoeconomics of obesity in China: a scoping review

References

• Hruby A, Hu F. The epidemiology of obesity: a big picture. PharmacoEconomics. 2015;33(7):673–689.
   PubMed Web of Science ®Google Scholar
• Windarti N, Hlaing S, Kakinaka M. Obesity Kuznets curve: international evidence. Public Health. 2019;169:26–35.
   PubMed Web of Science ®Google Scholar
• Tremmel M, Gerdtham U-G, Nilsson PM, et al. Economic burden of obesity: a systematic literature review. Int J Environ Res Public Health. 2017;14(4):435.
   PubMed Web of Science ®Google Scholar
• Ramachandran A, Snehalatha C. Rising burden of obesity in Asia. J.Obesity. 2010;2010: 868573.
   PubMedGoogle Scholar
• Zhao W, Zhai Y, Hu J, et al., Economic burden of obesity-related chronic diseases in Mainland China. Obesity Rev. 9(Suppl 1): 62–67. 2008.
   PubMedGoogle Scholar
• Shi J, Wang Y, Cheng W, et al. Direct health care costs associated with obesity in Chinese population in 2011. J Diabetes Complications. 2017;31(3):523–528.
   PubMed Web of Science ®Google Scholar
• Tong X, Wang X, Wang D, et al. Prevalence and ethnic pattern of overweight and obesity among middle-aged and elderly adults in China. Eur J Prev Cardiol. 2019;26(16):1785–1789. .
   PubMed Web of Science ®Google Scholar
• Reinhold T, Schultzendorff A, Müller-Riemenschneider F. The burden of overweight and obesity in the Asia-Pacific region. Obesity Rev. 2007;8(3):191–196.
   PubMed Web of Science ®Google Scholar
• Wang Y, Xue H, Sun M, et al. Prevention and control of obesity in China. Lancet Glob Health. 2019;7(9):e1166–e7.
   PubMed Web of Science ®Google Scholar
• Wang Y, Wang L, Qu W. New national data show alarming increase in obesity and noncommunicable chronic diseases in China. Eur J Clin Nutr. 2017;71(1):149–150.
   PubMed Web of Science ®Google Scholar
• Li M, Xue H, Jia P, et al. Pocket money, eating behaviors, and weight status among Chinese children: the Childhood Obesity Study in China mega-cities. Preventive Med. 2017;100:208–215.
   PubMed Web of Science ®Google Scholar
• He Y, Pan A, Wang Y, et al. Prevalence of overweight and obesity in 15.8 million men aged 15-49 years in rural China from 2010 to 2014. Sci Rep. 2017;7(1):5012. .
   PubMedGoogle Scholar
• Hua J, Zhang L, Gao D, et al. Prevalence of overweight and obesity among people aged 18 years and over between 2013 and 2018 in Hunan, China. Int J Environ Res Public Health. 2020;17(11):4048. .
   Web of Science ®Google Scholar
• Meng L, Xu H, Liu A, et al. The costs and cost-effectiveness of a school-based comprehensive intervention study on childhood obesity in China. PLoS One. 2013;8(10):e77971. .
   PubMed Web of Science ®Google Scholar
• Du W, Su C, Wang H, et al. Is density of neighbourhood restaurants associated with BMI in rural Chinese adults? A longitudinal study from the China health and nutrition survey. BMJ Open. 2014;4(4):e004528.
   PubMed Web of Science ®Google Scholar
• Flegal KM, Graubard BI, Williamson DF, et al. Excess deaths associated with underweight, overweight, and obesity. JAMA. 2005;293(15):1861–1867.
   PubMed Web of Science ®Google Scholar
• Abdelaal M, le Roux C, Docherty N. Morbidity and mortality associated with obesity. Ann Transl Med. 2017;5(7):161.
   PubMed Web of Science ®Google Scholar
• Chen Z, Yang G, Offer A, et al., Body mass index and mortality in China: a 15-year prospective study of 220 000 men. Int J Epidemiol. 41(2): 472–481. 2012. .
   PubMed Web of Science ®Google Scholar
• Gu D, He J, Duan X, et al. Body weight and mortality among men and women in China. JAMA. 2006;295(7):776–783. .
   PubMed Web of Science ®Google Scholar
• Wang S, Ma W, Yuan Z, et al. Association between obesity indices and type 2 diabetes mellitus among middle-aged and elderly people in Jinan, China: a cross-sectional study. BMJ Open. 2016;6(11):e012742. .
   PubMed Web of Science ®Google Scholar
• Loef M, Walach H. Midlife obesity and dementia: meta-analysis and adjusted forecast of dementia prevalence in the United States and China. Obesity. 2013;21(1):e51–5.
   PubMed Web of Science ®Google Scholar
• Zeng Q, He Y, Dong S, et al. Optimal cut-off values of BMI, waist circumference and waist height ratio for defining obesity in Chinese adults. Br J Nutr. 2014;112(10):1735–1744. .
   PubMed Web of Science ®Google Scholar
• Zhu Y, Wang Q, Pang G, et al. Association between body mass index and health-related quality of life: the “Obesity Paradox” in 21,218 adults of the Chinese general population. PloS One. 2015;10(6):e0130613. .
   PubMed Web of Science ®Google Scholar
• Flegal K, Kit B, Orpana H, et al. Association of all-cause mortality with overweight and obesity using standard body mass index categories: a systematic review and meta-analysis. JAMA. 2013;309(1):71–82.
   PubMed Web of Science ®Google Scholar
• Lv Y, Yuan J, Mao C, et al., Association of body mass index with disability in activities of daily living among Chinese adults 80 years of age or older. JAMA Network Open. 1(5): e181915. 2018. .
   PubMed Web of Science ®Google Scholar
• Schooling CM, Lam TH, Li ZB, et al. Obesity, physical activity, and mortality in a prospective Chinese elderly cohort. Arch Internal Med. 2006;166(14):1498–1504. .
   PubMedGoogle Scholar
• Chen Y, Banta D, Tang Z. Health technology assessment development in China. Int J Technol Assess Health Care. 2009;25(Suppl 1):202–209.
   PubMed Web of Science ®Google Scholar
• Liang W, Xie J, Fu H, et al. The role of health economics and outcomes research in health care reform in China. PharmacoEconomics. 2014;32(3):231–234.
   PubMed Web of Science ®Google Scholar
• Ma H, Jian W, Xu T, et al. Quality of pharmacoeconomic research in China: a systematic review. Medicine (Baltimore). 2016;95(41):e5114.
   PubMed Web of Science ®Google Scholar
• Kennedy-Martin T, Mitchell B, Boye K, et al. The health technology assessment environment in Mainland China, Japan, South Korea, and Taiwan-implications for the evaluation of diabetes mellitus therapies. Value in Health Regional Issues. 2014;3. 3
   Google Scholar
• Jiang S, Chen Z, Wu J, et al. Addressing methodological and ethical issues in practicing health economic evaluation in China. J Global Health. 2020;10(2):2.
   Web of Science ®Google Scholar
• Chen Y, Chi X, He Y, et al. Mapping of health technology assessment in China: situation analysis and international comparison. Int J Technol Assess Health Care. 2019;35(5):401–407.
   PubMed Web of Science ®Google Scholar
• É É, Goldman D, Messali A, et al. Do statins reduce the health and health care costs of obesity? PharmacoEconomics. 2015;33(7):723–734.
   PubMed Web of Science ®Google Scholar
• Finkelstein E, Kruger E, Karnawat S. Cost-effectiveness analysis of Qsymia for weight loss. PharmacoEconomics. 2015;33(7):699–706.
   PubMed Web of Science ®Google Scholar
• Song HJ, Kwon JW, Kim YJ, et al. Bariatric surgery for the treatment of severely obese patients in South Korea – Is it cost effective? Obes Surg. 2013;23(12):2058–2067.
   PubMed Web of Science ®Google Scholar
• Funk L, Jolles S, Voils C. Obesity as a disease: has the AMA resolution had an impact on how physicians view obesity? Surg Obes Relat Dis. 2016;12(7):1431–1435.
   PubMed Web of Science ®Google Scholar
• Medicare.gov. Bariatric surgery coverage. [ accessed October 21.2020] https://www.medicare.gov/coverage/bariatric-surgery 2020.
   Google Scholar
• National Health Security Administration, China. Interim rules on basic medical insurance drug coverage, 2020. accessed Oct 21.2020. http://www.nhsa.gov.cn/art/2020/7/31/art_37_3387.html
   Google Scholar
• Li Q, Cai L, Cui W, et al. Economic burden of obesity and four obesity-related chronic diseases in rural Yunnan Province, China. Public Health. 2018;164:91–98.
   PubMed Web of Science ®Google Scholar
• Tu Y, Wang L, Wei L, et al. Cost-utility of laparoscopic roux-en-Y gastric bypass in Chinese patients with type 2 diabetes and obesity with a BMI ≥ 27.5 kg/m2: a multi-center study with a 4-year follow-up of surgical cohort. Obes Surg. 2019;29(12):3978–3986. .
   PubMed Web of Science ®Google Scholar
• Wan B, Fang N, Guan W, et al. Cost-effectiveness of bariatric surgery versus medication therapy for obese patients with type 2 diabetes in China: a Markov analysis. J Diabetes Res. 2019;2019:1341963.
   PubMed Web of Science ®Google Scholar
• Wang H, Wang M, Wang J, et al. Cost-effectiveness analysis of comprehensive intervention programs to control blood glucose in overweight and obese type 2 diabetes mellitus patients based on a real-world setting: Markov modeling. Ann Transl Med. 2019;7(22):676. .
   PubMed Web of Science ®Google Scholar
• Popkin B, Kim S, Rusev E, et al. Measuring the full economic costs of diet, physical activity and obesity-related chronic diseases. Obesity Rev. 2006;7(3):271–293.
   PubMed Web of Science ®Google Scholar
• Yang T, Bian X, Chu X, et al. Pharmacoeconomic evaluation of surgical weight loss surgery and drug therapy for type 2 diabetes mellitus accompanied with obesity patients. Chin J Mod Appl Pharm. 2018;35(5):725–729.
   Google Scholar
• Zhang J, Shi X, Liang X. Economic costs of both overweight and obesity among Chinese urban and rural residents, in 2010. Zhonghua Liu Xing Bing Xue Za Zhi. 2013;34(6):598–600.
   PubMedGoogle Scholar
• Withrow D, Alter D. The economic burden of obesity worldwide: a systematic review of the direct costs of obesity. Obes Rev. 2011;12(2):131–141.
   PubMed Web of Science ®Google Scholar
• Yang L, Wu M, Cui B, et al. Economic burden of cardiovascular diseases in China. Expert Rev Pharmacoecon Outcomes Res. 2008;8(4):349–356.
   PubMedGoogle Scholar
• Hird TR, Zomer E, Owen A, et al. The impact of diabetes on productivity in China. Diabetologia. 2019;62(7):1195–1203. .
   PubMed Web of Science ®Google Scholar
• Chen S, Bloom DE. The macroeconomic burden of noncommunicable diseases associated with air pollution in China. Plos One. 2019;14(4):e0215663.
   PubMed Web of Science ®Google Scholar
• Clay E, Zhou J, Yi Z-M, et al. Economic burden for Alzheimer’s disease in China from 2010 to 2050: a modelling study. J Mark Access Health Policy. 2019;7(1):1667195.
   PubMedGoogle Scholar
• Liang YX, Wong O, Fu H, et al. The economic burden of pneumoconiosis in China. Occup Environ Med. 2003;60(6):383–384.
   PubMed Web of Science ®Google Scholar
• Linthicum MT, Snider JT, Vaithianathan R, et al. Economic burden of disease-associated malnutrition in China. Asia Pac J Public Health. 2015;27(4):407–417. .
   PubMed Web of Science ®Google Scholar
• Cremieux P. Policy makers’ views of obesity-related challenges around the world: an interview between Pierre Cremieux (of analysis group, Inc., and guest editor of this special issue) and policymakers from Brazil (Patricia Constante Jaime), Canada (Kimberly Elmslie), China (Bin Wang), France (François Crémieux), and the USA (Mark McClellan). PharmacoEconomics. 2015;33(7):619–628.
   PubMedGoogle Scholar
• Liu S, Chen Z, Han L, et al. Integrated multisectoral non-communicable disease prevention and control in China: a review of agencies and policies. J Glob Health. 2020;10(2):020304. .
   PubMed Web of Science ®Google Scholar
• Chen Z, Zhou L, Jiang S, et al. Identifying options of best value: use of economic evaluation in public health. China CDC Weekly. 2020;2(5):75–78.
   Google Scholar
• Dong Y, Jan C, Ma Y, et al. Economic development and the nutritional status of Chinese school-aged children and adolescents from 1995 to 2014: an analysis of five successive national surveys. Lancet Diabetes Endocrinol. 2019;7(4):288–299. .
   PubMed Web of Science ®Google Scholar
• Popkin BM, Du S, Zhai F, et al. Cohort profile: the China health and nutrition survey – monitoring and understanding socio-economic and health change in China, 1989–2011. Int J Epidemiol. 2010;39(6):1435–1440.
   PubMed Web of Science ®Google Scholar
• Li G, Zhang P, Wang J, et al. The long-term effect of lifestyle interventions to prevent diabetes in the China Da Qing diabetes prevention study: a 20-year follow-up study. Lancet. 2019;29(12):3978–3979. .
   Google Scholar
• Zheng R, Zhang X, Guan T, et al. The long-term effect of worksite community based intervention programme for hypertension and stroke among employees in Shougang. Int J Cardiol. 2011;12:S42.
   Google Scholar
• Goettler A, Grosse A, Sonntag D. Productivity loss due to overweight and obesity: a systematic review of indirect costs. BMJ Open. 2019;14(10):10.
   Google Scholar
• Sanders GD, Neumann PJ, Basu A, et al. Recommendations for conduct, methodological practices, and reporting of cost-effectiveness analyses: second panel on cost-effectiveness in health and medicine. JAMA. 2016;316(10):1093–1103. .
   PubMed Web of Science ®Google Scholar
• Eddy DM, Hollingworth W, Caro JJ, et al. The macroeconomic burden of noncommunicable diseases associated with air pollution in China. PLOS ONE. 2003;60(6):383–384.
   Google Scholar
• Haacker M, Hallett TB, Atun R. On time horizons in health economic evaluations. Health Policy Plan. 2020;35(9):1237–1243.
   Web of Science ®Google Scholar
• Neumann PJ, Sanders GD, Russell LB, Siegel JE, Ganiats TG. Cost-effectiveness in health and medicine. 2nd Edition, Oxford University Press, New York; 2016.
   Google Scholar
• Excellence N. Technical guidance for manufacturers and sponsors on making a submission to a technology appraisal. London: National Institute for Clinical Excellence; 2001.
   Google Scholar
• CADTH. Guidelines for the economic evaluation of health technologies. 4th ed ed. Canada: CADTH; 2017.
   Google Scholar
• Liu G, Wu J, Sun L, et al.ChinesePharmacoeconomicsGuidelines(2ndEdition).http://proa28198.pic40.websiteonline.cn/upload/0ikw.pdf; Committee of Pharmacoeconomics, Chinese Pharmaceutical Association, Beijing, China, 2019 [accessed Feb 1, 2020.2020].
   Google Scholar
• Drummond MF, Sculpher MJ, Claxton K, et al. Methods for the economic evaluation of health care programmes. New York: Oxford University Press; 2015.
   Google Scholar
• Yang F, Jiang S, He X-N, et al. Do rural residents in China understand EQ-5D-5L as intended? Evidence from a qualitative study. Pharmacoecon – Open;2020. doi: 10.1007/s41669-020-00212-z
   PubMed Web of Science ®Google Scholar
• Wong C, Mulhern B, Cheng G, et al. K.SF-6D population norms for the Hong Kong Chinese general population. Qual Life Res. 2018;27(9):2349–2359.
   PubMed Web of Science ®Google Scholar
• Ochalek J, Wang H, Gu Y, et al. Informing acost-effectiveness threshold for health technology assessment in China: Amarginal productivity approach. .
   Google Scholar
• Grosse SD. Assessing cost-effectiveness in healthcare: history of the $50,000 per QALY threshold. Expert Rev Pharmacoecon Outcomes Res. 2008;8(2):165–178.
   PubMedGoogle Scholar
• Cutler DM, Huckman RS. Technological development and medical productivity: the diffusion of angioplasty in New York state. J Health Econ. 2003;22(2):187–217.
   PubMed Web of Science ®Google Scholar
• Bertram MY, Lauer JA, De Joncheere K, et al. Cost–effectiveness thresholds: pros and cons. Bull World Health Organ. 2016;94(12):925.
   PubMed Web of Science ®Google Scholar
• CHARLS. China health and retirement longitudinal study followup 2015 release note. 2017 [ accessedFeb. 22, 2020]: http://charls.pku.edu.cn/Public/ashelf/public/uploads/document/2015-charls-wave4/application/CHARLS_2015_Release_Note.pdf
   Google Scholar